The local biotechnology industry is expected to grow rapidly in the coming years, but companies need to pair up with overseas partners to ensure growth and an international presence, industry experts said yesterday.
"We expect to see more than 25 percent growth in the local biotechnology industry over the next few years," said Johnsee Lee (
PHOTO: GEORGE TSORNG, TAIPEI TIMES
In 2001, there were 750 biotechnology companies in Taiwan generating US$3 billion in revenue. In the past two years combined, private companies invested more than NT$20 billion in biotechnology enterprises, Lee said.
"The industry has become three to four times bigger than it used to be, and we are seeing many new companies setting up," Lee said.
But the key for companies to continue to grow is finding overseas partners.
"Small companies need to collaborate and build alliances internationally," he said.
One of the venture capital companies working to bring overseas and Taiwanese companies together is the Taipei-based Cheng Xin Technology Development Corp (
"Part of what we do is tying up local companies with overseas partners for licensing and technology transfers," said Adeline Wong (
To encourage more local-international pair-ups, the government planned a themed month of biotechnology events for this month. Unfortunately SARS disrupted most of the international participation, forcing the organizers to postpone two core events to the fall.
The APEC Biotechnology Conference 2003 is now scheduled to take place on Sept. 28 and Sept. 29, and BioBusiness Asia 2003 will follow directly afterwards on Sept. 30 and Oct. 1. Twenty-four foreign biotech companies have been invited to present their business models to local hopefuls at the second event, Lee said yesterday.
The Bio Taiwan exhibition will start as planned today at the World Trade Center. The event is open only to trades, with no entry fee, everyday from 10:30am to 5pm until Sunday.
"The exhibition's 500 booths are all fully booked and we are expecting 100,000 visitors, making this the largest biotechnology event in Taiwan ever," Lee said.
One focus of the exhibition will be a SARS area, featuring companies that have worked on the genomic analysis and identification of the virus, diagnostic tools to detect the virus and possible vaccines and therapeutic treatments for sufferers.
At least one investor was looking forward to the exhibition.
"This is a very good opportunity to look at the better biotechnology companies in Taiwan all at once," said Willie Lin (
But one industry watcher was disappointed by the high proportion of government involvement in the exhibition.
"Of the 500 companies exhibiting, around 200 are government bodies or research institutes," said David Silver, director of Biotech-east.com, a Web site that promotes Taiwan's biotechnology and pharmaceutical industries. "I think it's a pity there aren't more private companies, but the SARS-related area will certainly be an interesting part of the event."
The government is banking on the success of the local biotechnology industry. Last May, President Chen Shui-bian (
But making money out of biotechnology may be a gamble.
"Sadly the investments so far have not been generating as much income as we had expected," Huang said. But Lin was much more upbeat.
"So far biotechnology companies are performing well compared with international standards. We are seeing pretty good results and are satisfied," he said.
China is to impose restrictions on exporting two metals used to make semiconductors and other electronics, a move that is likely to raise costs for hardware manufacturers and worsen geopolitical tensions over the race to develop advanced computing technology. Gallium and germanium, along with their chemical compounds, would be subject to export controls starting Aug. 1, the Chinese Ministry of Commerce said in a statement yesterday. Introducing the measures would serve national security and China’s national interest, the statement said. China is the leading producer of 20 critical raw materials, including gallium and germanium, as measured by its share of global mining.
The S&P Global Taiwan Manufacturing Purchasing Managers’ Index (PMI) was still below the 50 point threshold last month, indicating that operating conditions remained tough for local manufacturers due to weak end-market demand in the US and Europe. Last month’s reading was 44.8, up slightly from 44.3 in May, S&P Global said in a report yesterday. The index has been in negative territory for more than a year, S&P Global said. The health of Taiwanese manufacturers had deteriorated further at the end of the second quarter in light of a sharp retreat in production, along with a solid decline in new business, the
STOCK SHORTED: E Ink Holdings’ bottom line took a hit as SES-imagotag’s stock price crashed after short-seller Gotham City Research’s allegations of manipulation E Ink Holdings Inc (元太科技) yesterday said it has increased its holding of SES-imagotag in a gesture of support as its major customer put forward persuasive arguments against allegations of inflating revenue. The world’s sole e-paper display manufacturer said it has bought the shares after SES-imagotag’s stock price nosedived after being targeted by short-seller Gotham City Research LLC last week, E Ink chairman Johnson Lee (李政昊) told shareholders during its annual general meeting in Hsinchu yesterday. “SES-imagotag is a well-managed company. It is one of very few companies in Europe that still enjoyed fast growth in recent years,” Lee said.
CONTRACT CHIPMAKING: Expanding production at its Pyeongtaek fab and a new plant in Taylor, Texas, would boost its capacity sevenfold, the firm said Samsung Electronics Co’s chip foundry business is adding production capacity and more advanced manufacturing techniques, aiming to make gains on market leader Taiwan Semiconductor Manufacturing Co (TSMC, 台積電). The South Korean company said that it would introduce 2-nanometer production for mobile phone parts by 2025 and expand applications. Samsung would also significantly increase output in Pyeongtaek, South Korea, and Taylor, Texas, to shore up its foundry division, which makes chips for customers on a contract basis, the company said at a presentation on Tuesday in San Jose, California. The world’s largest memorychip maker is looking to catch up with TSMC while also
RSS